Answers are grounded in this paper and cite their sources.
Tumor-associated macrophages adopt suppressive states, but how tumor stress installs these programs remains unclear. Here, we identify syndecan-3 (SDC3) as a macrophage-intrinsic mechanosensory regulator by integrating in vivo functional screening, single-cell and spatial profiling, and genetic and pharmacological perturbation. SDC3+ macrophages accumulate in hypoxic, stiff tumor niches and suppress antitumor cytotoxic T-cell responses. Matrix stiffness increases mechanical loading on SDC3, reorganizes an SDC3-associated scaffold and opens suppressive chromatin loci. This program engages a CDK7–MAFB relay to induce TREM2, which functions as a required suppressive effector in mice. Human-cell assays support a species-specific TREM2-associated inhibition mechanism. Naldemedine engages TREM2, restores cytotoxic T-cell activity, improves tumor control and enhances immune-checkpoint blockade in vivo. These findings define a targetable SDC3–CDK7–MAFB–TREM2 axis linking hypoxia and tissue mechanics to macrophage-mediated immune evasion. Tumor associated macrophages (TAMs) are a main component of the immunosuppressive tumor microenvironment (TME). Here the authors identify syndecan-3 as a macrophage-intrinsic mechano-sensor that drives immunosuppression in the TME.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: